Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence

Published:1995-08 Issue:8971 Volume:346 Page:329-336
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wilcox R.G

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of mortality and major morbidity results from all randomised trials of more than 1000 patients;Fibrinolytics Therapy Trialists (FTT) Collaborative Group;Lancet,1994

2. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction and improved survival. Should the paradigm be expanded?;Braunwald;Circulation,1989

3. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator;Neuhaus;J Am Coll Cardiol,1989

4. Effectiveness of double bolus alteplase in the treatment of acute myocardial infarction;Purvis;Am J Cardiol,1991

5. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction;The GUSTO Investigators;N Engl J Med,1993

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reteplase versus Alteplase for Acute Ischemic Stroke;New England Journal of Medicine;2024-06-27

2. Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial;Stroke;2024-02

3. Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial;Stroke and Vascular Neurology;2024-01-29

4. Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review;Thrombosis Journal;2023-09-04

5. A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Streptokinase in the Management of Myocardial Infarction in Developing Countries;Cureus;2023-08-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3